Skip Navigation

Johns Hopkins Bloomberg School of Public Health

AIDS Linked to the Intravenous Experience Study

Upcoming Events

 

 
 
SHARE Study

The SHARE study is recruiting new study participants. SHARE is part of the longest-running and largest HIV research study in the U.S. This is a unique opportunity to contribute to the knowledge of HIV disease and HIV therapy over a lifetime. SHARE is NOT a treatment study and does NOT involve taking experimental medicines. You will continue to receive your medical care from your own medical care provider.

For more information, see the SHARE recruitment flyer.

SNAP Study

The SNAP Project is a research study exploring sexual health promotion strategies among African-American/Black men. Eligible participants will be paid.

For more information on eligibility and how to get involved, see the SNAP study recruitment flyer.

REPRIEVE Study

The REPRIEVE study is recruiting new participants to study heart disease prevention in people with HIV. This is a clinical trial to see whether Pitavastatin can prevent heart disease and heart disease related deaths in people with HIV infection who are taking HIV medications.

For more information, see the REPRIEVE recruitment flyer.

ACTG Hepatitis C Study

This ACTG study is recruiting new participants for a 5-year study of the impact of Hepatitis C treatment. No new medicines are provided by the study. Eligible participants will be paid.

For more information, see the ACTG Hepatitis C study flyer.

HIV/Hepatitis C Study

This study is recruiting new participants with both HIV and Hepatitis C. Treatment, lab work, and biopsies will be provided by the study. Participants will be paid for participation in the biopsy substudy.

For more information, see the HIV/Hepatitis C study flyer.

HIV-Negative Study

This study is recruiting HIV-negative transgender adults. Participants will be paid.

For more information, see the recruitment flyer.

.
.